80 FR 46323 - Manufacturer of Controlled Substances Registration: Sigma Aldrich Research Biochemicals, Inc.

DEPARTMENT OF JUSTICE
Drug Enforcement Administration

Federal Register Volume 80, Issue 149 (August 4, 2015)

Page Range46323-46324
FR Document2015-19166

Sigma Aldrich Research Biochemicals, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Sigma Aldrich Research Biochemicals, Inc. registration as a manufacturer of those controlled substances.

Federal Register, Volume 80 Issue 149 (Tuesday, August 4, 2015)
[Federal Register Volume 80, Number 149 (Tuesday, August 4, 2015)]
[Notices]
[Pages 46323-46324]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-19166]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Manufacturer of Controlled Substances Registration: Sigma Aldrich 
Research Biochemicals, Inc.

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Sigma Aldrich Research Biochemicals, Inc. applied to be 
registered as a manufacturer of certain basic classes of controlled 
substances. The Drug Enforcement Administration (DEA) grants Sigma 
Aldrich Research Biochemicals, Inc. registration as a manufacturer of 
those controlled substances.

SUPPLEMENTARY INFORMATION: By notice dated April 14, 2015, and 
published in the Federal Register on April 22, 2015,

[[Page 46324]]

80 FR 22557, Sigma Aldrich Research Biochemicals, Inc., 1-3 Strathmore 
Road, Natick, Massachusetts 01760-2447 applied to be registered as a 
manufacturer of certain basic classes of controlled substances. No 
comments or objections were submitted for this notice.
    The DEA has considered the factors in 21 U.S.C. 823(a) and 
determined that the registration of Sigma Aldrich Research 
Biochemicals, Inc. to manufacture the basic classes of controlled 
substances is consistent with the public interest and with United 
States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. The DEA investigated the company's 
maintenance of effective controls against diversion by inspecting and 
testing the company's physical security systems, verifying the 
company's compliance with state and local laws, and reviewing the 
company's background and history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above-named company is granted registration as a bulk 
manufacturer of the basic classes of controlled substances listed:

------------------------------------------------------------------------
               Controlled substance                       Schedule
------------------------------------------------------------------------
Cathinone (1235).................................  I
Methcathinone (1237).............................  I
Mephedrone (4-Methyl-N-methylcathinone) (1248)...  I
Aminorex (1585)..................................  I
Alpha-ethyltryptamine (7249).....................  I
Lysergic acid diethylamide (7315)................  I
Tetrahydrocannabinols (7370).....................  I
4-Bromo-2,5-dimethoxyamphetamine (7391)..........  I
4-Bromo-2,5-dimethoxyphenethylamine (7392).......  I
4-Methyl-2,5-dimethoxyamphetamine (7395).........  I
2,5-Dimethoxyamphetamine (7396)..................  I
3,4-Methylenedioxyamphetamine (7400).............  I
N-Hydroxy-3,4-methylenedioxyamphetamine (7402)...  I
3,4-Methylenedioxy-N-ethylamphetamine (7404).....  I
3,4-Methylenedioxymethamphetamine (7405).........  I
Dimethyltryptamine (7435)........................  I
Psilocybin (7437)................................  I
5-Methoxy-N,N-diisopropyltryptamine (7439).......  I
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470).....  I
N-Benzylpiperazine (7493)........................  I
MDPV (3,4-Methylenedioxypyrovalerone) (7535).....  I
Methylone (3,4-Methylenedioxy-N-methylcathinone)   I
 (7540).
Heroin (9200)....................................  I
Normorphine (9313)...............................  I
Amphetamine (1100)...............................  II
Methamphetamine (1105)...........................  II
Nabilone (7379)..................................  II
1-Phenylcyclohexylamine (7460)...................  II
Phencyclidine (7471).............................  II
Cocaine (9041)...................................  II
Codeine (9050)...................................  II
Ecgonine (9180)..................................  II
Levomethorphan (9210)............................  II
Levorphanol (9220)...............................  II
Meperidine (9230)................................  II
Metazocine (9240)................................  II
Methadone (9250).................................  II
Morphine (9300)..................................  II
Thebaine (9333)..................................  II
Levo-alphacetylmethadol (9648)...................  II
Remifentanil (9739)..............................  II
Sufentanil (9740)................................  II
Carfentanil (9743)...............................  II
Fentanyl (9801)..................................  II
------------------------------------------------------------------------

    The company plans to manufacture reference standards.

    Dated: July 29, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-19166 Filed 8-3-15; 8:45 am]
BILLING CODE P


Current View
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice of registration.
FR Citation80 FR 46323 

2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR